Sabloff M - Search Results

1

Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.

Maganti HB, Jrade H, Cafariello C, Manias Rothberg JL, Porter CJ, Yockell-Lelièvre J, Battaion HL, Khan ST, Howard JP, Li Y, Grzybowski AT, Sabri E, Ruthenburg AJ, Dilworth FJ, Perkins TJ, Sabloff M, Ito CY, Stanford WL. Maganti HB, et al. Among authors: sabloff m. Cancer Discov. 2018 Nov;8(11):1376-1389. doi: 10.1158/2159-8290.CD-17-0841. Epub 2018 Aug 16. Cancer Discov. 2018. PMID: 30115703 Free PMC article.

2

Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes.

Mozessohn L, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Liu Y, Earle CC, Cheung MC, Mittmann N, Buckstein R. Mozessohn L, et al. Among authors: sabloff m. JCO Oncol Pract. 2023 Apr;19(4):e559-e569. doi: 10.1200/OP.22.00668. Epub 2023 Feb 10. JCO Oncol Pract. 2023. PMID: 36763927 Free PMC article.

3

Monoclonal B cells detected in autologous PBSC grafts from patients with classical Hodgkin lymphoma: impact on relapse and survival following transplantation.

Takach S, Yang L, Ho J, Sabri E, Martin L, Halpenny M, Atkins H, Sabloff M, McDiarmid SA, Huebsch LB, Bence-Bruckler I, Giulivi A, Allan DS. Takach S, et al. Among authors: sabloff m. Bone Marrow Transplant. 2010 May;45(5):856-61. doi: 10.1038/bmt.2009.241. Epub 2009 Sep 21. Bone Marrow Transplant. 2010. PMID: 19767777

4

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.

Deol A, Sengsayadeth S, Ahn KW, Wang HL, Aljurf M, Antin JH, Battiwalla M, Bornhauser M, Cahn JY, Camitta B, Chen YB, Cutler CS, Gale RP, Ganguly S, Hamadani M, Inamoto Y, Jagasia M, Kamble R, Koreth J, Lazarus HM, Liesveld J, Litzow MR, Marks DI, Nishihori T, Olsson RF, Reshef R, Rowe JM, Saad AA, Sabloff M, Schouten HC, Shea TC, Soiffer RJ, Uy GL, Waller EK, Wiernik PH, Wirk B, Woolfrey AE, Bunjes D, Devine S, de Lima M, Sandmaier BM, Weisdorf D, Khoury HJ, Saber W. Deol A, et al. Among authors: sabloff m. Cancer. 2016 Oct;122(19):3005-3014. doi: 10.1002/cncr.30140. Epub 2016 Jun 17. Cancer. 2016. PMID: 27315441 Free PMC article.

5

Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.

Barrera-Ramirez J, Lavoie JR, Maganti HB, Stanford WL, Ito C, Sabloff M, Brand M, Rosu-Myles M, Le Y, Allan DS. Barrera-Ramirez J, et al. Among authors: sabloff m. Stem Cell Rev Rep. 2017 Dec;13(6):817-825. doi: 10.1007/s12015-017-9762-0. Stem Cell Rev Rep. 2017. PMID: 28918518 Free PMC article.

6

Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature.

Pi L, Rooprai J, Allan DS, Atkins H, Bredeson C, Fulcher AJ, Ito C, Ramsay T, Shorr, Stanford WL, Sabloff M, Christou G. Pi L, et al. Among authors: sabloff m. Leuk Res. 2019 Nov;86:106222. doi: 10.1016/j.leukres.2019.106222. Epub 2019 Sep 5. Leuk Res. 2019. PMID: 31522038

7

Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies.

Maganti H, Visram A, Shorr R, Fulcher J, Sabloff M, Allan DS. Maganti H, et al. Among authors: sabloff m. Leuk Res. 2020 Oct;97:106442. doi: 10.1016/j.leukres.2020.106442. Epub 2020 Aug 27. Leuk Res. 2020. PMID: 32877869

8

A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia.

Bryant A, Sheppard D, Sabloff M, Delbaere M, Maze R, Allan D, Atkins H, Bence-Bruckler I, Faught C, Huebsch L, Tay J, Zanke B, Bredeson C. Bryant A, et al. Among authors: sabloff m. Leuk Lymphoma. 2015 Jan;56(1):135-40. doi: 10.3109/10428194.2014.883072. Epub 2014 Jul 17. Leuk Lymphoma. 2015. PMID: 24913512

9

Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.

Chandran P, Le Y, Li Y, Sabloff M, Mehic J, Rosu-Myles M, Allan DS. Chandran P, et al. Among authors: sabloff m. Leuk Res. 2015 Apr;39(4):486-93. doi: 10.1016/j.leukres.2015.01.013. Epub 2015 Feb 2. Leuk Res. 2015. PMID: 25703353

10

Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.

Le Y, Fraineau S, Chandran P, Sabloff M, Brand M, Lavoie JR, Gagne R, Rosu-Myles M, Yauk CL, Richardson RB, Allan DS. Le Y, et al. Among authors: sabloff m. Stem Cell Rev Rep. 2016 Apr;12(2):235-44. doi: 10.1007/s12015-015-9639-z. Stem Cell Rev Rep. 2016. PMID: 26649729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters